09:33 EST AxoGen (AXGN) trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on AXGN: AxoGen Reports Strong Q3 2024 Revenue Growth AxoGen reports Q3 adjusted EPS 7c, consensus 1c AxoGen reiterates FY24 revenue view of $182M-$186M, consensus $184.72M AXGN Upcoming Earnings Report: What to Expect? AxoGen Seeks Accelerated FDA Review for Avance Nerve Graft®